HIF1A and cancer: Studies have demonstrated that HIF-1α can reduce DNA damage in cancer cells through an unknown mechanism, further contributing to the drug resistance of several cancer types, including triple-negative breast cancer (TNBC) and prostate cancer (PC) (172).